You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 45 No. 10, October 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  REGULAR DEPARTMENTS
 This Article
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Pathologic Heterogeneity of Alzheimer's Disease-Reply

William Bondareff, MD, PhD
Department of Psychiatry and Behavioral Sciences University of Southern California Health Science Campus 2025 Zonal Ave Los Angeles, CA 90033

Christopher Mountjoy, FRCPsych
(UK)

St Andrew's Hospital Northampton NN1 5DG United Kingdom

Martin Roth, MD, ScD, FRCP, FRCPsych
(UK)

Department of Psychiatry Clinical School University of Cambridge Cambridge CB2 2QQ United Kingdom

Martin N. Rossor, MD, MRCP
The National Hospitals for Nervous Diseases Queens Square London WC1N 3BG United Kingdom

Leslie L. Iversen, MA, PhD, FRS
Merck Sharp & Dohme Research Laboratories Neuroscience Research Centre Terlings Park Eastwick Road Harlow, Essex CM20 2QR United Kingdom

Gavin P. Reynolds, PhD
Department of Pathology Queen's Medical Centre University Hospital Nottingham NG7 2UH United Kingdom

Arch Gen Psychiatry. 1988;45(10):963.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Reply.—

Mann and colleagues counted nLC neurons in 46 patients with AD (mean age, 77.73 ±9.42 years). They found two groups: one with a mean neuronal loss of 70% and the other with a mean neuronal loss of 28%. This compares well with our description of AD-1 (with a 20% loss of nLC neurons) and AD-2 (with an 80% loss). While these findings suggest the subdivision of AD into two subtypes, our case for subdivision rests on more evidence; in particular, on differences in neocortical norepinephrine concentration, choline acetyltransferase activity, plaques, and tangles.

Like Mann and associates, we found that although there were some dips in the distribution curve of nLC neuronal counts, clear modes could not be discerned. Discriminant function analyses, however, showed the existence of two groups, which were better differentiated by age at death than by loss of nLC neurons.

Although it is not known with certainty . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.